These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ovarian cancer. Bapsy PP. J Indian Med Assoc; 2012 Dec 04; 110(12):894-7. PubMed ID: 23936953 [No Abstract] [Full Text] [Related]
3. Treatment of germ cell tumors of the ovary. Williams SD. Semin Oncol; 1991 Jun 04; 18(3):292-6. PubMed ID: 1645889 [No Abstract] [Full Text] [Related]
4. [Clinical analysis of 15 cases of malignant ovarian germ cell tumors with lung metastasis]. Liu Y, Ren T, Feng FZ, Wan XR, Shen K, Xiang Y. Zhonghua Fu Chan Ke Za Zhi; 2012 Jan 04; 47(1):40-4. PubMed ID: 22455692 [Abstract] [Full Text] [Related]
5. Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Colombo N, Peiretti M, Garbi A, Carinelli S, Marini C, Sessa C, ESMO Guidelines Working Group. Ann Oncol; 2012 Oct 04; 23 Suppl 7():vii20-6. PubMed ID: 22997450 [No Abstract] [Full Text] [Related]
6. An overview of current diagnosis and treatment in ovarian cancer. Mould T. Int J Gynecol Cancer; 2012 May 04; 22 Suppl 1():S2-4. PubMed ID: 22543914 [No Abstract] [Full Text] [Related]
7. Treatment of ovarian cancer in young women. Gershenson DM. Clin Obstet Gynecol; 2012 Mar 04; 55(1):65-74. PubMed ID: 22343230 [Abstract] [Full Text] [Related]
8. Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ray-Coquard I, Morice P, Lorusso D, Prat J, Oaknin A, Pautier P, Colombo N, ESMO Guidelines Committee. Ann Oncol; 2018 Oct 01; 29(Suppl 4):iv1-iv18. PubMed ID: 29697741 [No Abstract] [Full Text] [Related]
9. Outcome of recurrent and persistent disease of malignant ovarian germ cell tumor: a retrospective analysis at King Chulalongkorn Memorial Hospital. Lertkhachonsuk R, Manchana T, Termrungruanglert W, Vasuratna A, Sittisomwong T, Worasethsin P, Sirisabya N, Khemapech N, Tresukosol D. J Med Assoc Thai; 2006 Feb 01; 89(2):138-44. PubMed ID: 16578998 [Abstract] [Full Text] [Related]
10. [Treatment of malignant ovarian germ cell tumors with relapse or failed in primary therapy]. Yang JX, Wang HB, Shen K, Huang HF, Pan LY, Wu M. Zhonghua Fu Chan Ke Za Zhi; 2009 Apr 01; 44(4):273-6. PubMed ID: 19570465 [Abstract] [Full Text] [Related]
11. Early-stage ovarian cancer: to treat or not to treat. Young RC. J Natl Cancer Inst; 2003 Jan 15; 95(2):94-5. PubMed ID: 12529336 [No Abstract] [Full Text] [Related]
12. Limited efficacy of platinum-based adjuvant treatment on the outcome of borderline ovarian tumors. Vasconcelos I, Olschewski J, Braicu I, Sehouli J. Eur J Obstet Gynecol Reprod Biol; 2015 Mar 15; 186():26-33. PubMed ID: 25602531 [Abstract] [Full Text] [Related]
13. [Malignant ovarian germ cell tumors--clinical characteristics and analysis of outcomes]. Miedzińska-Maciejewska M, Bobkiewicz P, Gawrychowski K. Ginekol Pol; 2011 May 15; 82(5):338-43. PubMed ID: 21851031 [Abstract] [Full Text] [Related]
14. [Chemotherapy for ovarian malignant germ cell tumors]. Nagai Y, Inamine M, Kudaka W, Aoki Y. Nihon Rinsho; 2012 Jun 15; 70 Suppl 4():648-55. PubMed ID: 23156326 [No Abstract] [Full Text] [Related]
15. Ovarian cancer of epithelial origin--an update. Menczer J. Isr J Med Sci; 1993 Aug 15; 29(8):477-83. PubMed ID: 8407278 [No Abstract] [Full Text] [Related]
16. [Decision-making of treatment and relative problems about recurrent and drug-resistant gynecologic neoplasms]. Xie X, Cheng XD. Zhonghua Fu Chan Ke Za Zhi; 2010 Nov 15; 45(11):801-3. PubMed ID: 21211274 [No Abstract] [Full Text] [Related]
17. [Adenocarcinoma of the ovary as a study model of cancers and their treatments]. Belpomme D, Filippi MH, Le Bonniec M, Héritier F. Bull Cancer; 1993 Feb 15; 80(2):115-20. PubMed ID: 8173162 [No Abstract] [Full Text] [Related]